Apogee Therapeutics (APGE) Short Interest Ratio & Short Volume $39.42 -0.94 (-2.33%) As of 02:43 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Apogee Therapeutics Short Interest DataApogee Therapeutics (APGE) has a short interest of 10.38 million shares, representing 28.66% of the float (the number of shares available for trading by the public). This marks a 7.79% increase in short interest from the previous month. The short interest ratio (days to cover) is 14.8, indicating that it would take 14.8 days of the average trading volume of 522,545 shares to cover all short positions.Current Short Interest10,380,000 sharesPrevious Short Interest9,630,000 sharesChange Vs. Previous Month+7.79%Dollar Volume Sold Short$407.42 millionShort Interest Ratio14.8 Days to CoverLast Record DateApril 30, 2025Outstanding Shares46,047,000 sharesFloat Size36,220,000 sharesShort Percent of Float28.66%Today's Trading Volume170,731 sharesAverage Trading Volume522,545 sharesToday's Volume Vs. Average33% Short Selling Apogee Therapeutics? Sign up to receive the latest short interest report for Apogee Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartAPGE Short Interest Over TimeAPGE Days to Cover Over TimeAPGE Percentage of Float Shorted Over Time Apogee Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/202510,380,000 shares $407.42 million +7.8%28.7%14.8 $39.25 4/15/20259,630,000 shares $316.35 million +11.6%25.9%14.1 $32.85 3/31/20258,630,000 shares $322.42 million +5.8%23.4%12.6 $37.36 3/15/20258,160,000 shares $325.91 million +5.2%22.1%13.6 $39.94 2/28/20257,760,000 shares $243.97 million -6.7%21.0%13.3 $31.44 2/15/20258,320,000 shares $304.01 million -5.8%23.0%15.3 $36.54 1/31/20258,830,000 shares $365.21 million +3.9%24.3%16.7 $41.36 1/15/20258,500,000 shares $343.91 million +5.1%23.4%17.4 $40.46 12/31/20248,090,000 shares $366.48 million +1.5%22.3%18 $45.30 12/15/20247,970,000 shares $354.67 million +8.3%22.0%17.8 $44.50 Get the Latest News and Ratings for APGE and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Apogee Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 11/30/20247,360,000 shares $332.30 million +11.2%20.3%16.1 $45.15 11/15/20246,620,000 shares $312.80 million -2.8%18.3%15.8 $47.25 10/31/20246,810,000 shares $354.39 million -0.9%18.9%17.3 $52.04 10/15/20246,870,000 shares $377.03 million -5.0%18.9%17.4 $54.88 9/30/20247,230,000 shares $424.69 million -11.7%19.9%17.1 $58.74 9/15/20248,190,000 shares $420.80 million -1.1%22.6%17.8 $51.38 8/31/20248,280,000 shares $423.69 million +1.1%22.8%18.6 $51.17 8/15/20248,190,000 shares $371.01 million +5.3%22.0%18.5 $45.30 7/31/20247,780,000 shares $378.89 million -9.6%21.1%16.5 $48.70 7/15/20248,610,000 shares $425.16 million +8.4%23.4%18.9 $49.38 6/30/20247,940,000 shares $312.44 million +18.0%21.4%17.4 $39.35 6/15/20246,730,000 shares $276.87 million +3.5%18.2%14.4 $41.14 5/31/20246,500,000 shares $296.66 million +36.0%17.6%11.3 $45.64 5/15/20244,780,000 shares $254.77 million -1.2%12.3%6.7 $53.30 4/30/20244,840,000 shares $243.45 million +6.4%14.0%7.2 $50.30 4/15/20244,550,000 shares $241.47 million -1.1%13.0%6.6 $53.07 3/31/20244,600,000 shares $305.67 million +50.8%13.1%6.8 $66.45 3/15/20243,050,000 shares $208.35 million -2.6%9.8%4.8 $68.31 2/29/20243,130,000 shares $108.99 million -5.2%14.6%6.1 $34.82 2/15/20243,300,000 shares $117.94 million -12.0%15.4%9.9 $35.74 1/31/20243,750,000 shares $125.63 million No Change17.6%11.4 $33.50 APGE Short Interest - Frequently Asked Questions What is Apogee Therapeutics' current short interest? Short interest is the volume of Apogee Therapeutics shares that have been sold short but have not yet been closed out or covered. As of April 30th, investors have sold 10,380,000 shares of APGE short. 28.66% of Apogee Therapeutics' shares are currently sold short. Learn More on Apogee Therapeutics' current short interest. What is a good short interest ratio for Apogee Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. APGE shares currently have a short interest ratio of 15.0. Learn More on Apogee Therapeutics's short interest ratio. Which institutional investors are shorting Apogee Therapeutics? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Apogee Therapeutics: Jane Street Group LLC, Caption Management LLC, and Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Apogee Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 28.66% of Apogee Therapeutics' floating shares are currently sold short. Is Apogee Therapeutics' short interest increasing or decreasing? Apogee Therapeutics saw a increase in short interest in April. As of April 30th, there was short interest totaling 10,380,000 shares, an increase of 7.8% from the previous total of 9,630,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Apogee Therapeutics' float size? Apogee Therapeutics currently has issued a total of 46,047,000 shares. Some of Apogee Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Apogee Therapeutics currently has a public float of 36,220,000 shares. How does Apogee Therapeutics' short interest compare to its competitors? 28.66% of Apogee Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Apogee Therapeutics: BridgeBio Pharma, Inc. (11.68%), Blueprint Medicines Co. (8.76%), Elanco Animal Health Incorporated (5.00%), Legend Biotech Co. (3.67%), TG Therapeutics, Inc. (14.56%), Verona Pharma plc (9.87%), Lantheus Holdings, Inc. (10.28%), Axsome Therapeutics, Inc. (8.53%), Grifols, S.A. (1.26%), Nuvalent, Inc. (13.62%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Spotify Technology S.A. ($4.67 billion), Charter Communications, Inc. ($4.58 billion), Capital One Financial Co. ($4.47 billion), The Kroger Co. ($2.56 billion), Reddit, Inc. ($2.23 billion), Rivian Automotive, Inc. ($2.16 billion), Live Nation Entertainment, Inc. ($1.90 billion), SoFi Technologies, Inc. ($1.85 billion), Zscaler, Inc. ($1.75 billion), and Omnicom Group Inc. ($1.75 billion). View all of the most shorted stocks. What does it mean to sell short Apogee Therapeutics stock? Short selling APGE is an investing strategy that aims to generate trading profit from Apogee Therapeutics as its price is falling. APGE shares are trading down $1.06 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Apogee Therapeutics? A short squeeze for Apogee Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of APGE, which in turn drives the price of the stock up even further. How often is Apogee Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including APGE, twice per month. The most recent reporting period available is April, 30 2025. More Short Interest Resources from MarketBeat Related Companies BridgeBio Pharma Short Interest Data Blueprint Medicines Short Interest Data Elanco Animal Health Short Interest Data Legend Biotech Short Interest Data TG Therapeutics Short Interest Data Verona Pharma Short Interest Data Lantheus Short Interest Data Axsome Therapeutics Short Interest Data Grifols Short Interest Data Nuvalent Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:APGE) was last updated on 5/23/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredTrump’s Bitcoin Reserve is No Accident…Bitcoin's supply is being drained at unprecedented rates, but while most investors focus solely on Bitcoin, th...Crypto 101 Media | SponsoredIs President Trump Lying To You With This?President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to ...Colonial Metals | SponsoredJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Apogee Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Apogee Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.